Trajectory of anti-SARS-COV-2 IgG antibodies from onset of symptoms to 6 months in a cohort of Pakistani patients
Infect Dis (Lond)
.
2022 Jun;54(6):460-463.
doi: 10.1080/23744235.2022.2033312.
Epub 2022 Feb 11.
Authors
Maria Mehmood
1
,
Haleema Usman Khan
2
,
Muhammad Ihtesham Khan
1
,
Ishaq Khan
3
,
Rajaa Mohammad Al-Raddadi
4
,
Steve Harakeh
5
,
Yasar Mehmood Yousafzai
2
6
Affiliations
1
Department of Pathology, Khyber Medical College, Peshawar, Pakistan.
2
Institute of Pathology and Diagnostic Medicine, Khyber Medical University, Peshawar, Pakistan.
3
Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.
4
Community Medicine Department, King Abdulaziz University, Jeddah, Saudi Arabia.
5
Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
6
Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
PMID:
35147051
DOI:
10.1080/23744235.2022.2033312
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Viral
COVID-19*
Cohort Studies
Humans
Immunoglobulin G
Pakistan / epidemiology
Substances
Antibodies, Viral
Immunoglobulin G